b-Myb antibody, N-term
GTX77893
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetMYBL2
Overview
- SupplierGeneTex
- Product Nameb-Myb antibody, N-term
- Delivery Days Customer9
- Application Supplier NoteWB: 0.2-2.5 ug/ml. IHC-P: 2-10 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5-1 mg/ml
- ConjugateUnconjugated
- Gene ID4605
- Target nameMYBL2
- Target descriptionMYB proto-oncogene like 2
- Target synonymsB-MYB, BMYB, myb-related protein B, myb-like protein 2, v-myb avian myeloblastosis viral oncogene homolog-like 2, v-myb myeloblastosis viral oncogene homolog-like 2
- HostRabbit
- IsotypeIgG
- Protein IDP10244
- Protein NameMyb-related protein B
- Scientific DescriptionThe protein encoded by this gene, a member of the MYB family of transcription factor genes, is a nuclear protein involved in cell cycle progression. The encoded protein is phosphorylated by cyclin A/cyclin-dependent kinase 2 during the S-phase of the cell cycle and possesses both activator and repressor activities. It has been shown to activate the cell division cycle 2, cyclin D1, and insulin-like growth factor-binding protein 5 genes. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2013]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Patel AJ et al., 2019 Oct 22, Proc Natl Acad Sci U S ARead more
- Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models. Parisi F et al., 2010, Breast Cancer ResRead more






